Bellevue Life Sciences-WRNTOSRHWPreferred / convertible
13F holders, Q4 2025 (December 31)17holders −3
0new positions
2sold out
1famous investor
$0.10avg. 13F price*
At the end of Q4 2025, 17 institutions reported holding Bellevue Life Sciences-WRNT (OSRHW) in their 13F filings, down 3 from Q3 2025. 0 opened new positions and 2 sold out. The largest holders were Boothbay Fund Management, LLC ($175K), Toronto Dominion Bank ($25K) and Polar Asset Management Partners Inc. ($17K). One famous investor held it David E. Shaw ( of D. E. Shaw & Co.'s portfolio).
- Company
- Bellevue Life Sciences-WRNT
- Filed as
- OSR HLDGS INC (Q4 2025)
- CUSIP
- 68840D110
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 2 | $2K |
All 13F filers, Q3 2025 → Q4 2025: 283 shares bought and 50,433 shares sold, net −50,150 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 17 holders
| Boothbay Fund Management, LLC | — | No change | 311,040 | $175K |
| Toronto Dominion Bank | — | Reduce -0.0% | 489,272 | $25K |
| Polar Asset Management Partners Inc. | — | No change | 360,000 | $17K |
| Periscope Capital Inc. | — | No change | 299,900 | $15K |
| Clear Street Group Inc. | — | Reduce -0.1% | 292,083 | $15K |
| LMR Partners LLP | — | No change | 253,001 | $13K |
| Rivernorth Capital Management, LLC | — | No change | 250,000 | $13K |
| Saba Capital Management, L.P. | — | No change | 250,000 | $12K |
| D. E. Shaw & Co. | — | No change | 150,000 | $7K |
| Wolverine Asset Management LLC | — | Reduce -0.3% | 111,585 | $6K |
| Centiva Capital, LP | — | No change | 100,000 | $4K |
| Mint Tower Capital Management B.V. | — | No change | 75,000 | $4K |
| Aristeia Capital, L.L.C. | — | No change | 73,341 | $3K |
| SkyView Investment Advisors, LLC | — | No change | 30,000 | $2K |
| Gabelli Funds LLC | — | No change | 27,050 | $1K |
| GABELLI & Co INVESTMENT ADVISERS, INC. | — | No change | 20,800 | $1K |
| Flow Traders U.S. LLC | — | Add +1.2% | 23,730 | $1K |
"% of holder's portfolio" is OSRHW's weight in each manager's 13F, not the share of Bellevue Life Sciences-WRNT the manager owns.